(Reuters) - The world's second-largest biotechnology company had net income of $747 million, or 70 cents per share, compared with year-earlier net income of $531 million, or 49 cents per share.
Read more at Reuters.com Business News
Read more at Reuters.com Business News
No comments:
Post a Comment